353 related articles for article (PubMed ID: 15199752)
1. [Hairy cell leukemia, Japanese variant, successfully treated with cladribine].
Miyazaki M; Taguchi A; Sakuragi S; Mitani N; Matsuda K; Shinohara K
Rinsho Ketsueki; 2004 May; 45(5):405-7. PubMed ID: 15199752
[TBL] [Abstract][Full Text] [Related]
2. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
[TBL] [Abstract][Full Text] [Related]
3. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
Araki H; Matsunaga T; Murase K; Kuroda H; Kuribayashi K; Terui T; Niitsu Y
Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122
[TBL] [Abstract][Full Text] [Related]
4. [European-American-type hairy cell leukemia without splenomegaly, treated successfully with deoxycoformycin].
Muta T; Okamura T; Oshima K; Kikuchi M; Niho Y
Rinsho Ketsueki; 2001 May; 42(5):426-31. PubMed ID: 11452464
[TBL] [Abstract][Full Text] [Related]
5. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
7. Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide.
Strupp C; Fenk R; Kündgen A; Gattermann N; Haas R; Germing U
Leuk Res; 2005 Aug; 29(8):967-9. PubMed ID: 15978949
[TBL] [Abstract][Full Text] [Related]
8. [Successful treatment of hairy cell leukemia with pentostatin].
Fujita H; Koharazawa H; Nishida H; Terada S; Morishita T; Kuroyama Y; Ohata M; Ishigatsubo Y
Rinsho Ketsueki; 2001 Jul; 42(7):537-42. PubMed ID: 11524843
[TBL] [Abstract][Full Text] [Related]
9. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
Zák P; Chrobák L; Dĕdic K; Podzimek K
Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
[TBL] [Abstract][Full Text] [Related]
10. [Hairy cell leukemia successfully treated with deoxycoformycin].
Matsuda A; Jinnai I; Mizuno H; Sakata T; Kusumoto S; Kayano H; Takeuchi H; Bessho M; Saito M; Katayama I
Rinsho Ketsueki; 1992 Nov; 33(11):1685-90. PubMed ID: 1469784
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia].
Sakai R; Yamazaki E; Sakamoto H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801
[TBL] [Abstract][Full Text] [Related]
12. [Polyclonal B-cell lymphocytosis with clinical and hematological features resembling hairy cell leukemia].
Kanbayashi H; Nagata K; Tanaka T; Matsuda S; Sakuma H; Maruyama Y; Machii T
Rinsho Ketsueki; 1998 Jul; 39(7):493-8. PubMed ID: 9750456
[TBL] [Abstract][Full Text] [Related]
13. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
Yang MH; Ho CH
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
[TBL] [Abstract][Full Text] [Related]
14. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
Dedic K; Zák P
Neoplasma; 2004; 51(1):56-8. PubMed ID: 15004661
[TBL] [Abstract][Full Text] [Related]
15. Development of hairy cell leukemia in a patient with antiphospholipid syndrome.
Diz-Kucukkaya R; Dincol G; Kamali S; Kural F; Inanc M
Lupus; 2007; 16(4):286-8. PubMed ID: 17439936
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hairy cell leukemia with cladribine].
Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
[TBL] [Abstract][Full Text] [Related]
17. [50-year-old man with weight loss and splenomegaly].
Austein T; Schmitt A
Dtsch Med Wochenschr; 2009 Feb; 134(6):251-2. PubMed ID: 19180417
[No Abstract] [Full Text] [Related]
18. The role of interleukin-6 in a patient with polyclonal hairy B-cell lymphoproliferative disorder: a case report.
Okamoto A; Inaba T; Fujita N
Lab Hematol; 2007; 13(4):124-7. PubMed ID: 18192143
[TBL] [Abstract][Full Text] [Related]
19. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
Urasiński I; Zdziarska B; Krygier-Stojałowska A
Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
[TBL] [Abstract][Full Text] [Related]
20. Cladribine: from the bench to the bedside--focus on hairy cell leukemia.
Greyz N; Saven A
Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
